Current Assets 更改
Acadia Pharmaceuticals USD 675.3M 59.17M 2024-03
Agios Pharmaceuticals USD 663.63M 170.21M 2024-03
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Amgen USD 28.03B 2.3B 2024-03
Bayer EUR 40.17B 2.61B 2024-03
Biogen USD 6.76B 103.1M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
Incyte USD 4.85B 203.69M 2024-03
Insmed USD 758.72M 170.34M 2024-03
Ionis Pharmaceuticals USD 2.42B 226.18M 2024-03
Moderna USD 9.6B 725M 2024-03
Neurocrine Biosciences USD 1.8B 149.1M 2024-03
PTC Therapeutics USD 1.17B 49.89M 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Roche Holding CHF 33.45B 2.47B 2023-12
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
Ultragenyx Pharmaceutical USD 595.97M 3.22M 2024-03
United Therapeutics USD 3.25B 302.3M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03



BioMarin Pharmaceutical 流动资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.